HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aldosterone enhances IGF-I-mediated signaling and biological function in vascular smooth muscle cells.

Abstract
The IGF-I pathway and renin-angiotensin-aldosterone axis are both involved in the pathogenesis of hypertension and atherosclerosis, but no information is available about IGF-I and aldosterone interaction or their potential synergistic effects in vascular smooth muscle cells (VSMCs). The aims of this study were to investigate whether aldosterone influences IGF-I signaling and to determine the mechanism(s) by which aldosterone affects IGF-I function. Aldosterone resulted in significant increases in the Akt (1.87 ± 0.24, P < 0.001), MAPK (1.78 ± 0.13, P < 0.001), p70S6kinase (1.92 ± 0.15, P < 0.001), IGF-I receptor (1.69 ± 0.05, P < 0.01), and insulin receptor substrate-1 (1.7 ± 0.04, P < 0.01) (fold increase, mean ± SEM, n = 3) phosphorylation responses to IGF-I compared with IGF-I treatment alone. There were also significant increases in VSMC proliferation, migration, and protein synthesis (1.63 ± 0.03-, 1.56 ± 0.08-, and 1.51 ± 0.04-fold increases compared with IGF-I alone, respectively, n = 3, P < 0.001). Aldosterone induced osteopontin (OPN) mRNA expression and activation of αVβ3-integrin as well as an increase in the synthesis of IGF-I receptor. The enhancing effects of aldosterone were inhibited by eplerenone (10 μmol/liter), actinomycin-D (20 nmol/liter), and an anti-αVβ3-integrin antibody that blocks OPN binding. The antioxidant N-acetylcysteine (2 mmol/liter) completely inhibited the ability of aldosterone to induce any of these changes. In conclusion, our results show that aldosterone enhances IGF-I signaling and biological actions in VSMCs through induction of OPN followed by its subsequent activation of the αVβ3-integrin and by increasing IGF-I receptor. These changes are mediated in part through increased oxidative stress. The findings suggest a new mechanism by which aldosterone could accelerate the development of atherosclerosis.
AuthorsTeresa Cascella, Yashwanth Radhakrishnan, Laura A Maile, Walker H Busby Jr, Katherine Gollahon, Annamaria Colao, David R Clemmons
JournalEndocrinology (Endocrinology) Vol. 151 Issue 12 Pg. 5851-64 (Dec 2010) ISSN: 1945-7170 [Electronic] United States
PMID20881255 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Integrin alphaVbeta3
  • Osteopontin
  • Aldosterone
  • Insulin-Like Growth Factor I
  • Proto-Oncogene Proteins c-akt
  • Ribosomal Protein S6 Kinases, 70-kDa
  • Mitogen-Activated Protein Kinase Kinases
Topics
  • Aldosterone (pharmacology)
  • Animals
  • Aorta (cytology)
  • Cell Movement
  • Cell Proliferation
  • Cells, Cultured
  • Insulin-Like Growth Factor I (metabolism)
  • Integrin alphaVbeta3 (genetics, metabolism)
  • Mitogen-Activated Protein Kinase Kinases (genetics, metabolism)
  • Muscle, Smooth, Vascular (cytology, drug effects)
  • Myocytes, Smooth Muscle (drug effects, physiology)
  • Osteopontin (genetics, metabolism)
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt
  • Ribosomal Protein S6 Kinases, 70-kDa (genetics, metabolism)
  • Signal Transduction (physiology)
  • Swine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: